Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating The Efficacy, Safety, And Pharmacokinetics Of SAGE-547 Injection In The Treatment Of Adult Female Subjects With Severe Postpartum Depression
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female participants diagnosed with severe postpartum depression.
Age
18 - 45 years
Sex
FEMALE
Healthy Volunteers
No
Sage Investigational Site
Atlanta, Georgia, United States
Sage Investigational Site
Worcester, Massachusetts, United States
Sage Investigational Site
Chapel Hill, North Carolina, United States
Sage Investigational Site
Philadelphia, Pennsylvania, United States
Start Date
December 15, 2015
Primary Completion Date
June 22, 2016
Completion Date
June 22, 2016
Last Updated
September 15, 2025
21
ACTUAL participants
SAGE-547
DRUG
Placebo
DRUG
Lead Sponsor
Supernus Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions